Literature DB >> 26709655

SOCS2: physiological and pathological functions.

Elisabeth Letellier1, Serge Haan2.   

Abstract

Suppressors of cytokine signalling (SOCS) proteins are modulators of cytokine and growth factor signalling whose aberrant regulation has been linked to a variety of inflammatory and neoplastic diseases. SOCS proteins are able to act as substrate-recruiting component of E3-ubiquitin ligase complexes and target interacting proteins for degradation. At least some of the family members can also directly inhibit tyrosine kinases such as Janus Kinases (JAK). The most studied family members, CIS, SOCS1, SOCS2 and SOCS3 are important regulators of the JAK-STAT pathway. Here, we focus on SOCS2 and review its biological function as well as its implication in pathological processes. Furthermore, we take advantage of the known crystal structures of SOCS2 to discuss the potential effects of a selection of SOCS2 mutations that were identified in tumour tissues.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26709655     DOI: 10.2741/E760

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  31 in total

1.  Deletion of Pofut1 in Mouse Skeletal Myofibers Induces Muscle Aging-Related Phenotypes in cis and in trans.

Authors:  Deborah A Zygmunt; Neha Singhal; Mi-Lyang Kim; Megan L Cramer; Kelly E Crowe; Rui Xu; Ying Jia; Jessica Adair; Isabel Martinez-Pena Y Valenzuela; Mohammed Akaaboune; Peter White; Paulus M Janssen; Paul T Martin
Journal:  Mol Cell Biol       Date:  2017-05-02       Impact factor: 4.272

Review 2.  The Functional Role of Prostate Cancer Metastasis-related Micro-RNAs.

Authors:  Ulrich H Weidle; Alexandra Epp; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2019 Jan-Feb       Impact factor: 4.069

3.  KIAA0317 regulates pulmonary inflammation through SOCS2 degradation.

Authors:  Travis B Lear; Alison C McKelvey; John W Evankovich; Shristi Rajbhandari; Tiffany A Coon; Sarah R Dunn; James D Londino; Bryan J McVerry; Yingze Zhang; Eleanor Valenzi; Christine L Burton; Rachael Gordon; Sebastien Gingras; Karina C Lockwood; Michael J Jurczak; Robert Lafyatis; Mark J Shlomchik; Yuan Liu; Bill B Chen
Journal:  JCI Insight       Date:  2019-10-03

4.  Differential Expression of Ccn4 and Other Genes Between Metastatic and Non-metastatic EL4 Mouse Lymphoma Cells.

Authors:  Manpreet S Chahal; H Teresa Ku; Zhihong Zhang; Christian M Legaspi; Angela Luo; Mandi M Hopkins; Kathryn E Meier
Journal:  Cancer Genomics Proteomics       Date:  2016 11-12       Impact factor: 4.069

5.  The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.

Authors:  Meiling Cui; Ji Sun; Jianjing Hou; Tao Fang; Xin Wang; Chao Ge; Fangyu Zhao; Taoyang Chen; Haiyang Xie; Ying Cui; Ming Yao; Jinjun Li; Hong Li
Journal:  Tumour Biol       Date:  2016-07-28

6.  Integrative Analysis for Identification of Therapeutic Targets and Prognostic Signatures in Non-Small Cell Lung Cancer.

Authors:  Özgür Cem Erkin; Betül Cömertpay; Esra Göv
Journal:  Bioinform Biol Insights       Date:  2022-04-06

Review 7.  SOCS molecules: the growing players in macrophage polarization and function.

Authors:  Dexi Zhou; Lu Chen; Kui Yang; Hui Jiang; Wenke Xu; Jiajie Luan
Journal:  Oncotarget       Date:  2017-08-04

8.  The ubiquitin ligase Cullin5SOCS2 regulates NDR1/STK38 stability and NF-κB transactivation.

Authors:  Indranil Paul; Tanveer S Batth; Diego Iglesias-Gato; Amna Al-Araimi; Ibrahim Al-Haddabi; Amira Alkharusi; Gunnar Norstedt; Jesper V Olsen; Fahad Zadjali; Amilcar Flores-Morales
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

9.  Genomic evidence of adaptive evolution in the reptilian SOCS gene family.

Authors:  Tian Xia; Lei Zhang; Guolei Sun; Xiufeng Yang; Honghai Zhang
Journal:  PeerJ       Date:  2021-06-24       Impact factor: 2.984

10.  Suppressors of cytokine signaling in tuberculosis.

Authors:  Shih-Wei Lee; Chi-Wei Liu; Jia-Ying Hu; Li-Mei Chiang; Chih-Pin Chuu; Lawrence Shih-Hsin Wu; Yung-Hsi Kao
Journal:  PLoS One       Date:  2017-04-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.